Phantom Neuro, a Texas-based provider of robotic orthopedic systems – that help people with limb deficits regain complete control over their lives, raised $19M in Series A funding.
Phantom Neuro, a Texas-based provider of robotic orthopedic systems – that help people with limb deficits regain complete control over their lives, raised $19M in Series A funding.
Ottobock led the investment round with participation from Draper Associates, Time BioVentures, Breakout Ventures, Risk and Return, LionBird Ventures, and others.
Ottobock led the investment round with participation from Draper Associates, Time BioVentures, Breakout Ventures, Risk and Return, LionBird Ventures, and others.
Phantom Neuro said it intends to use the fresh funds to complete its first human trials, conduct preclinical testing, advance regulatory submissions, and expand R&D to explore broader applications of its technology beyond prosthetic limbs.
Phantom Neuro said it intends to use the fresh funds to complete its first human trials, conduct preclinical testing, advance regulatory submissions, and expand R&D to explore broader applications of its technology beyond prosthetic limbs.
Including the latest funding round, Phantom Neuro has raised $28M in funding to date. In 2022, Phantom Neuro raised $3.25M in Seed funding and, subsequently, $6M in expanded Seed funding.
Including the latest funding round, Phantom Neuro has raised $28M in funding to date. In 2022, Phantom Neuro raised $3.25M in Seed funding and, subsequently, $6M in expanded Seed funding.
Phantom Neuro, spun out of Johns Hopkins University School of Medicine, offers its peripheral neural interface technology, Phantom X.
Phantom Neuro, spun out of Johns Hopkins University School of Medicine, offers its peripheral neural interface technology, Phantom X.
Phantom X is designed to restore natural movement and functionality for amputees and individuals with mobility impairments, allowing robotic devices to function as seamless extensions of the human body.
Phantom X is designed to restore natural movement and functionality for amputees and individuals with mobility impairments, allowing robotic devices to function as seamless extensions of the human body.
"Phantom Neuro is transforming the way people interact with assistive devices, and their minimally invasive neural interface technology represents an exciting step forward for the field," said Ottobock CEO, Oliver Jakobi.
"Phantom Neuro is transforming the way people interact with assistive devices, and their minimally invasive neural interface technology represents an exciting step forward for the field," said Ottobock CEO, Oliver Jakobi.
As part of the investment, Ottobock will join Phantom Neuro's Board of Directors, bringing expertise in global prosthetics and exoskeleton markets to support Phantom's commercialization efforts.
As part of the investment, Ottobock will join Phantom Neuro's Board of Directors, bringing expertise in global prosthetics and exoskeleton markets to support Phantom's commercialization efforts.